Skip to content
Home/Companies/Pharma/Rubicon Research

Rubicon Research

Pharma·United States·Active
Entry
–
Hold
–
Status
Active

Who owns Rubicon Research?

Rubicon Research is an American Pharma company, currently owned by General Atlantic.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
General Atlantic
Investor
General Atlantic
General Atlantic Partners (Bermuda) IV, L.P. · 2019 · Growth

Key facts

HQUnited States
SectorPharma

More from General Atlantic Partners (Bermuda) IV, L.P.

Other portfolio companies in the same fund.

dLocal
Active
Fintech
Futu Holdings Limited
Futu Holdings Limited
Active
FintechChina
Doctolib
Doctolib
Active
HealthTechFrance· 2017

More General Atlantic portfolio companies

From the same investor, across funds.

360 ONE
Active
SoftwareUS
58.com
Active
E-commerceChina
80 Acres Farms
80 Acres Farms
Active
FoodTechUS
A Place for Mom
A Place for Mom
Active
Business ServicesUS
A-Max
A-Max
Active
Business ServicesUS
ABB E-Mobility
ABB E-Mobility
Active
MobilitySwitzerland

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Rubicon Research?

Rubicon Research is currently owned by General Atlantic, through General Atlantic Partners (Bermuda) IV, L.P..

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue